These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


243 related items for PubMed ID: 9846813

  • 1. Cytokine secretion of myelin basic protein reactive T cells in patients with multiple sclerosis.
    Windhagen A, Anderson DE, Carrizosa A, Balashov K, Weiner HL, Hafler DA.
    J Neuroimmunol; 1998 Nov 02; 91(1-2):1-9. PubMed ID: 9846813
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. T-cell reactivity to multiple myelin antigens in multiple sclerosis patients and healthy controls.
    Hellings N, Barée M, Verhoeven C, D'hooghe MB, Medaer R, Bernard CC, Raus J, Stinissen P.
    J Neurosci Res; 2001 Feb 01; 63(3):290-302. PubMed ID: 11170179
    [Abstract] [Full Text] [Related]

  • 8. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis.
    Zhang J, Markovic-Plese S, Lacet B, Raus J, Weiner HL, Hafler DA.
    J Exp Med; 1994 Mar 01; 179(3):973-84. PubMed ID: 7509366
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Reactivity pattern and cytokine profile of T cells primed by myelin peptides in multiple sclerosis and healthy individuals.
    Tejada-Simon MV, Hong J, Rivera VM, Zhang JZ.
    Eur J Immunol; 2001 Mar 01; 31(3):907-17. PubMed ID: 11241296
    [Abstract] [Full Text] [Related]

  • 11. Pulse cyclophosphamide plus methylprednisolone induces myelin-antigen-specific IL-4-secreting T cells in multiple sclerosis patients.
    Takashima H, Smith DR, Fukaura H, Khoury SJ, Hafler DA, Weiner HL.
    Clin Immunol Immunopathol; 1998 Jul 01; 88(1):28-34. PubMed ID: 9683547
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Antigen-specific TGF-beta1 secretion with bovine myelin oral tolerization in multiple sclerosis.
    Fukaura H, Kent SC, Pietrusewicz MJ, Khoury SJ, Weiner HL, Hafler DA.
    Ann N Y Acad Sci; 1996 Feb 13; 778():251-7. PubMed ID: 8610978
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cytokine profile of myelin basic protein-reactive T cells in multiple sclerosis and healthy individuals.
    Hermans G, Stinissen P, Hauben L, Van den Berg-Loonen E, Raus J, Zhang J.
    Ann Neurol; 1997 Jul 13; 42(1):18-27. PubMed ID: 9225681
    [Abstract] [Full Text] [Related]

  • 18. Glatiramer acetate (copolymer-1)-specific, human T cell lines: cytokine profile and suppression of T cell lines reactive against myelin basic protein.
    Dabbert D, Rösner S, Krämer M, Schöll U, Tumani H, Mäder M, Weber F.
    Neurosci Lett; 2000 Aug 11; 289(3):205-8. PubMed ID: 10961665
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.